Latest COVID-19 Research & Evidence — 05/11/20

 

Worcestershire Health Libraries: 

Latest COVID-19 Research & Evidence — 05/11/20

 

Research

 

Title: SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19

Description: Virus-neutralizing monoclonal antibodies are predicted to reduce viral load, ameliorate symptoms, and prevent hospitalization. This study involved patients receiving either a neutralizing antibody or placebo infusion.

Available from: https://www.nejm.org/doi/pdf/10.1056/NEJMoa2029849?articleTools=true

 

Title: Lung volume reduction and infection localization revealed in big data CT imaging of COVID-19

Description: Using CT image, 3389 COVID-19 patients, 1593 community-acquired pneumonia (CAP) patients, and 1707 non-pneumonia subjects were included to explore the different patterns of lung and lung infection.

Available from: https://www.sciencedirect.com/scien...pid=1-s2.0-S1201971220323006-main.pdf

 

Title: Analysis of humoral immune responses in SARS-CoV-2 infected patients

Description: Here, the humoral immune response of a cohort of 143 COVID-19 patients from the University Hospital Frankfurt/Main, Germany was characterized.

Available from: https://academic.oup.com/jid/advance-article-pdf/doi/10.1093/infd...1016/jiaa680.pdf

 

Guidance

 

Title: Neurological associations of COVID-19

Description: In this rapid review, the authors explore and present provisional case definitions for the association of COVID-19 with neurological disease.

Available from: https://www.thelancet.com/action/showPdf?pii=S1474-4422%2820%2930221-0

 

Title: COVID-19 diagnosis and management (Updated 30/10/20)

Description: The BMJ COVID-19 clinical guidance page provides information on the theory, diagnosis, management, and follow-up of COVID-19 infection.

Available from: https://bestpractice.bmj.com/topics/en-gb/3000201

 

Expert Opinions

 

Title: Harms of public health interventions against COVID-19 must not be ignored

Description: The harmful consequences of public health choices should be explicitly considered and transparently reported to limit their damage, say Itai Bavli and colleagues.

Available from: https://www.bmj.com/content/bmj/371/bmj.m4074.full.pdf

 

Title: Who should be prioritised for COVID-19 vaccines?

Description: ‘As effective vaccines and preventive medications become available for COVID-19, demand is likely to outstrip supply, so we need to develop a strategy to ensure maximum public health and societal benefits’.

Available from: https://www.thelancet.com/action/showPdf?pii=S0140-6736%2820%2932224-8

 

For additional support with accessing the publications above, visit www.wkp.nhs.uk